Loading clinical trials...
Loading clinical trials...
The purpose of this study is to determine the oral dose level at which the investigative drug, Proellex, is able induce menstruation.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Repros Therapeutics Inc.
NCT06533865 · FHA (Functional Hypothalamic Amenorrhea)
NCT07010146 · Bone Strength, Bone Density, and more
NCT06800170 · Amenorrhea, Oligomenorrhea, and more
NCT06583408 · Hypothalamic Amenorrhea, Functional, Hypothalamic Amenorrhea, and more
NCT06933888 · Hypothalamic Amenorrhea, Functional
Advances in Health Inc.
Houston, Texas
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions